The association between adiponectin G276T gene polymorphic marker and abdominal obesity in a Kyrgyz population
https://doi.org/10.14341/probl201561146-50
Abstract
A population of ethnic Kyrgyz was examined with a view to elucidating the relationship between the adiponectin G276T gene polymorphic locus and the development of abdominal obesity (AO). The study included 288 subjects at the age between 40 and 70 years. 139 of them (81 women and 58 men) presented with AO while 149 without obesity (62 women and 87 men) constituted the control group. The measured anthropometric parameters included arterial pressure, blood glucose, insulin, and leptin levels, blood lipid composition. Genotypes of adiponectin (AN) G276T gene polymorphism were identified by means of PCR-RFLP analysis. The relationship between the presence of the adiponectin G276T gene polymorphic and the development of abdominal obesity in the women was demonstrated. Specifically, 31% of the women with AO were carriers of T allele compared with 17% in the control group (χ2=7.89; p =0.005). The GT + TT genotype and carriage of T allele were associated with an increased risk of development of abdominal obesity (OR=2.5; 95% CI = 1.25-4.97 for the genotype and OR = 2.2; 95% CI = 1.26-4.000 for the allele). No such relationship was documented among men. The women with AO and GT+TT genotype more frequently than homozygotes presented with type 2 diabetes mellitus (64 and 37% respectively; p=0.017), hypertriglyceridemia (41 and 16.2% respectively; p=0.016), and enhanced blood glucose level (7.74±3.3 and 6.52±1.17; p=0.033). Moreover, their HOMA index was higher than in the homozygotes (3.5±1.7 and 2.63±1.24 respectively; p=0.02). It is concluded that the adiponectin G276T gene polymorphic variant in the women of Kyrgyz ethnicity is associated with abdominal obesity, type 2 diabetes mellitus, hyperglycemia, and hypertriglyceridemia.
About the Authors
Zh T Isakova
Institute of Molecular Biology, Bishkek, Kyrgyz Republic
E T Talaibekova
Institute of Molecular Biology, Bishkek, Kyrgyz Republic
O S Lunegova
National Centre of Cardiology and Therapy, Bishkek, Kyrgyz Republic
D A Asambarva
Institute of Molecular Biology, Bishkek, Kyrgyz Republic
A S Kerimkulova
National Centre of Cardiology and Therapy, Bishkek, Kyrgyz Republic
A A Aldashev
Institute of Molecular Biology, Bishkek, Kyrgyz Republic
References
1. Haslam DW, James WPT. Obesity. The Lancet. 2005;366(9492):1197-1209. doi: 10.1016/s0140-6736(05)67483-1.
2. Айтбаев К.А., Хамзамулин Р.О., Мейманалиев Т.М., и др. Эпидемиология ишемической болезни сердца и артериальной гипертонии среди постоянных жителей высокогорья Тянь-Шаня и Памира. Актуальные проблемы кардиологии в зонах нового экономического освоения. - Иркутск; 1978. - С. 27-28.
3. Полупанов А.Н., Халматов А.Н., Алтымышева А.Т., и др. Распространенность сердечно-сосудистых факторов риска среди жителей Кыргызской Республики. Распространенность метаболических факторов риска. // Центрально-Азиатский Медицинский журнал. - 2013. - Т. 19. - №4 - С. 34-38.
4. Whitehead JP, Richards AA, Hickman IJ, et al. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes, Obesity and Metabolism. 2006;8(3):264-280. doi: 10.1111/j.1463-1326.2005.00510.x
5. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 2002;8(11):1288-1295. doi: 10.1038/nm788
6. Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes. Rev. 2005;6(1):13-21. doi: 10.1111/j.1467-789X.2005.00159.x
7. Takahashi M, Arita Y, Yamagata K, et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Int. J. Obes. 2000;24(7):861-868. doi: 10.1038/sj.ijo.0801244
8. Sheng T, Yang K. Adiponectin and its association with insulin resistance and type 2 diabetes. Journal of Genetics and Genomics. 2008;35(6):321-326. doi: 10.1016/s1673-8527(08)60047-8
9. Siitonen N, Pulkkinen L, Lindström J, et al. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med. Genet. 2011;12(1):5. doi: 10.1186/1471-2350-12-5
10. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46(4):459-469. doi: 10.1007/s00125-003-1074-z
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972;18(6):499-502.
12. Hotta K, Funahashi T, Bodkin NL, et al. Circulating Concentrations of the Adipocyte Protein Adiponectin Are Decreased in Parallel With Reduced Insulin Sensitivity During the Progression to Type 2 Diabetes in Rhesus Monkeys. Diabetes. 2001;50(5):1126-1133. doi: 10.2337/diabetes.50.5.1126.
13. Kadowaki T. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006;116(7):1784-1792. doi: 10.1172/jci29126.
14. Lin C-H. Influence of Adiponectin Gene Polymorphisms on Adiponectin Serum Level and Insulin Resistance Index in Taiwanese Metabolic Syndrome Patients. The Chinese Journal of Physiology. 2012;55(6):405-411. doi: 10.4077/cjp.2012.baa081
15. Comizio R, Pietrobelli A, Tan YX, et al. Total body lipid and triglyceride response to energy deficit: relevance to body composition models. American Journal of Physiology - Endocrinology and Metabolism. 1998;274(5):E860-E866.
16. Halaas J, Gajiwala K, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269(5223):543-546. doi: 10.1126/science.7624777
17. Yu SY, Ryu HK, Park HJ, et al. Adiponectin gene SNP 276G → T, nutrient intakes, and cardiovascular disease risk in Korean type 2 DM patients. Nutrition research and practice. 2007;1(4):363. doi: 10.4162/nrp.2007.1.4.363
18. Filippi E, Sentinelli F, Trischitta V, et al. Association of the human adiponectin gene and insulin resistance. Eur. J. Hum. Genet. 2003;12(3):199-205. doi: 10.1038/sj.ejhg.5201120
19. Salmenniemi U, Zacharova J, Ruotsalainen E, et al. Association of Adiponectin Level and Variants in the Adiponectin Gene with Glucose Metabolism, Energy Expenditure, and Cytokines in Offspring of Type 2 Diabetic Patients. The Journal of Clinical Endocrinology & Metabolism. 2005;90(7):4216-4223. doi: 10.1210/jc.2004-2289
20. Fredriksson J, Carlsson E, Orho-Melander M, et al. A polymorphism in the adiponectin gene influences adiponectin expression levels in visceral fat in obese subjects. Int. J. Obes. 2005;30(2):226-232. doi: 10.1038/sj.ijo.0803138.
21. González-Sánchez JL, Zabena CA, Martínez-Larrad MT, et al. An SNP in the Adiponectin Gene Is Associated with Decreased Serum Adiponectin Levels and Risk for Impaired Glucose Tolerance. Obesity. 2005;13(5):807-812. doi: 10.1038/oby.2005.91
22. Hara K, Boutin P, Mori Y, et al. Genetic Variation in the Gene Encoding Adiponectin Is Associated With an Increased Risk of Type 2 Diabetes in the Japanese Population. Diabetes. 2002;51(2):536-540. doi: 10.2337/diabetes.51.2.536
Review
For citations:
Isakova Zh.T., Talaibekova E.T., Lunegova O.S., Asambarva D.A., Kerimkulova A.S., Aldashev A.A. The association between adiponectin G276T gene polymorphic marker and abdominal obesity in a Kyrgyz population. Problems of Endocrinology. 2015;61(1):46-50. (In Russ.) https://doi.org/10.14341/probl201561146-50
Views:
460
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
